Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

SYNBIOTICS CORPORATION

UEI: FMNSBMMF3MH7

SYNBIOTICS CORPORATION is a federal contractor, registered under UEI FMNSBMMF3MH7. It has been awarded $5,738,019 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing, Pharmaceutical Preparation Manufacturing, and In-Vitro Diagnostic Substance Manufacturing. Top awarding agencies include Department Of Agriculture and Other agencies (1 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

FMNSBMMF3MH7

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

19

All time

Active

0

Currently performing

Completed

19

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Agriculture$5.7M100%
Other agencies (1 agencies, <0.5% each)$492.10%
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with SYNBIOTICS CORPORATION

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for SYNBIOTICS CORPORATION

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in SYNBIOTICS CORPORATION's top NAICS codes and agencies

NAICS: 325413
New
Federal
6550--Blood Type IVD Reagents
Solicitation # 36C26227Q0043
The Department of Veterans Affairs, through the Network Contract Office 22, is seeking quotations for solicitation 36C26227Q0043 to establish a Blanket Purchase Agreement for blood type IVD reagents, supplies, and consumables for manual testing at VISN 22 facilities. The contract is structured with a 12-month base ordering period and four subsequent 12-month option periods, for a total potential duration of five years. This is a commercial products and services acquisition under FAR Part 12, with an emphasis on FDA regulatory compliance, potency requirements, and strict cold-chain and temperature-monitoring controls during shipment. All items must be quoted as F.O.B. destination and delivered Monday through Friday between 8am and 4pm. Award will be based on the best value to the government, evaluated through a comparative assessment of technical understanding, price, and quality, regulatory compliance, and product traceability. Technical evaluation considers the offeror's ability to provide a full antigen profile and their procedures for handling nonconforming or defective products. Pricing will be evaluated based on the total cost for the base period and all option periods, including a six-month price addition for the final performance period per FAR 52.217-8. Quotations must be submitted via email to the contract specialist by November 16, 2026, and must include a completed five-year pricing spreadsheet, a past performance questionnaire, and required certifications regarding telecommunications and trade agreements.
262-NETWORK Contract Office 22 (36C262)

POSTED

about 19 hours ago

DEADLINE

in 16 days
View Details
NAICS: 325413
New
Federal
Reagents and consumables for Roche immunostainers
Solicitation # 75N98027Q00026
Solicitation 75N98027Q00026 is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract issued by the National Institutes of Health Office of Logistics and Operations. The objective is to procure proprietary reagents, kits, and consumables compatible with the National Cancer Institute's Roche Ventana Benchmark ULTRA and Benchmark Plus immunostainers. The contract includes a base year starting December 1, 2026, with four subsequent option years, carrying a minimum value of 20,000 dollars and a maximum value of 1.5 million dollars. The scope of work extends beyond supplies to include no-cost software upgrades, VConnect software coverage, and professional consultation from scientists and engineers. The contractor must adhere to strict quality and delivery standards, including overnight shipping using industry-best practices such as dry or wet ice, and ensuring all reagents have expiration dates exceeding 12 months from the shipping date. Deliveries are f.o.b. destination to Bethesda, Maryland, and must typically be completed within five days of a task order. Award will be based on a best value tradeoff evaluation considering technical proposal, equipment capability, delivery, and price. Offerors must provide a Unique Entity Identifier, Taxpayer Identification Number, and business size certification, with responses due by November 16, 2026.
National Institutes Of Health Olao

POSTED

about 19 hours ago

DEADLINE

in 16 days
View Details
NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

in 18 days
View Details
NAICS: 325412
New
Federal
6505--FY27 Lenalidomide BPA
Solicitation # 36C26227Q0083
The Department of Veterans Affairs, through Network Contracting Office 22, has issued this Sources Sought Notice and Request for Information to identify qualified sources for a Health Service Area 5.3 Blanket Purchase Agreement. The government seeks providers capable of supplying Lenalidomide medication in multiple dosage strengths, specifically 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg oral capsules. The medication will be delivered to eight participating VA Medical Centers across Arizona, California, and New Mexico. Due to the nature of the medication, the contractor must hold Food and Drug Administration Risk Evaluation and Mitigation Strategy certification to dispense the product and must ensure strict adherence to handling, storage, and temperature control regulations to maintain medication integrity. This is not a formal solicitation, and responses are intended for market research and planning purposes to inform future acquisition decisions. The anticipated period of performance is one year from the date of award, with orders placed on an as-needed basis via approved purchase orders. Interested respondents must provide a comprehensive capabilities statement, business size status relative to NAICS 325412, and details regarding their status as a manufacturer or authorized distributor. Submissions must also address compliance with the Buy American Act, the Non-Manufacturer Rule, and limitations on subcontracting. All responses must be submitted via email to the designated contracting officer by November 12, 2026.
262-NETWORK Contract Office 22 (36C262)

POSTED

about 19 hours ago

DEADLINE

in 12 days
View Details